ALNY - Alnylam Pharmaceuticals Q1 2023 Earnings Preview

2023-05-03 13:37:29 ET

• Alnylam Pharmaceuticals ( NASDAQ: ALNY ) is scheduled to announce Q1 earnings results on Thursday, May 4th, before market open.
• The consensus EPS Estimate is -$1.43 (+4.0% Y/Y) and the consensus Revenue Estimate is $312.53M (+46.5% Y/Y).
• Over the last 2 years, ALNY has beaten EPS estimates 13% of the time and has beaten revenue estimates 50% of the time.
• Over the last 3 months, EPS estimates have seen 3 upward revisions and 2 downward. Revenue estimates have seen 4 upward revisions and 8 downward.

For further details see: